Diagnoses Disease
105
5
8
53
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Research Maturity
53 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.0%
1 terminated out of 105 trials
98.1%
+11.6% vs benchmark
0%
0 trials in Phase 3/4
4%
2 of 53 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 53 completed trials
Clinical Trials (105)
Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea
Optimizing Bronchopulmonary Cancer Screening
HEARTBEAT-TROP. Polyethylene Glycol Precipitation to Unmask Macrotroponin
Socioeconomic Inequalities in the Diagnosis and Treatment of Colon and Ovarian Cancer in England Between 2016-2017
Artificial Intelligence for Highly Myopic Cataract
Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIV
Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases
Evaluation of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images
Measuring Skin Elasticity in Lymphedema Patients
Asthma Diagnosis Verified by Lung Function
Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
GP Response to Decontextualised Risk
TB-CAPT EXULTANT - HIV
TB-CAPT CORE Truenat Trial
Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema
Can VI-RADS/ADC Accurately Stage Bladder Cancer??
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
TB-CAPT MTB/XDR Study
Detection of Lipoarabinomannan in Urine Evaluation of the STANDARDTMF TBLAMFIA and Its Impact on the Initial TB Diagnosis